查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1629330

肾去神经设备市场，按技术、按产品、最终用户、国家和地区 - 2025-2032 年全球行业分析、市场规模、市场份额和预测

Renal Denervation Devices Market, By Technology, By Product, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2024年，肾臟去神经设备市场规模为2.5109亿美元，2025年至2032年复合年增长率为40.98%。

去肾神经设备市场-市场动态

高血压盛行率上升

由于高血压盛行率不断上升，预计去肾神经装置的市场未来将会发展。当流经动脉的血液压力持续过高时，称为高血压。对于顽固性高血压患者，去肾神经术（一种基于导管的手术）已成为可行的治疗选择。去肾交感神经术是治疗高血压的一种微创实验性治疗方法，但药物并没有改善。例如，2023年1月，美国密西西比州卫生部门密西西比州卫生部报告称，2021年密西西比州约有100万成年密西西比人（43.9%）患有高血压。多发性硬化症的比例将高于美国（多发性硬化症：43.9%，美国：32.2%）。因此，由于高血压发生率的上升，去肾神经装置的市场将会扩大。

去肾神经设备市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2025-2032）每年将以 40.98% 左右的复合年增长率成长

基于技术细分，射频消融预计将在 2024 年呈现最大市场份额

根据最终用户细分，医院是 2024 年的领先细分市场

按地区划分，北美是 2024 年的主要收入来源

去肾神经设备市场細項分析：

全球肾去神经设备市场根据技术、产品、最终用户和地区进行细分。

根据技术，市场分为射频消融、近距离放射治疗、基于超音波能量的 RDN、化学消融等。到 2024 年，射频消融术类别将占据市场主导地位，因为其已建立的市场地位以及使用该技术进行的大量成功手术。这项技术自问世以来就得到了广泛应用，它利用射频能量来破坏过度活跃的肾臟神经。例如，印度Kavery 医院于2024 年5 月推出了一种基于射频的新型肾臟去神经治疗方法，用于治疗持续性高血压。药性高血压方面显示出良好的效果，凸显了该技术的市场领先地位。

根据最终用户，市场分为医院、诊所、心血管研究中心和其他。到 2024 年，医院类别因其先进的基础设施、高技能的人员以及复杂流程的资源而占据主导市场份额。由于完善的报销结构和支持性医疗政策使患者更容易接受最先进的治疗，这些设施在处理难治性高血压病例方面非常成功。除了核心职责外，医院对于评估新型去肾神经疗法的安全性和有效性的临床试验也至关重要。这项研究推动了该领域的发展，也有助于将新颖的工具和方法儘早整合到标准医疗实践中。这些机构透过积极参与试验并帮助开发实证程序来增强高血压患者的治疗方案。

去肾神经设备市场 - 地理洞察

2024 年，北美在去肾神经装置行业中处于领先地位，这主要是由于显着的技术进步和大量的 FDA 批准请求。 2023年，FDA授权「Symplicity Spyral系统和基于超音波的Paradise装置」作为美国两种肾臟去神经装置之一。此外，该地区的主导地位归因于多种因素，包括人口老化、生活方式的改变以及高血压的高盛行率。市场的成长也主要是由生产高效设备的研发努力的增加所推动的。本地新产品的增加是推动去肾神经装置市场成长的另一个面向。

由于手术的持久效果、高血压发病率上升和技术进步等因素，欧洲去肾神经装置市场预计将显着发展。例如，根据健康改善和差异办公室的资料，2021 年英国有8,457,600 人患有高血压。的受访者表示他们了解自己的血压。此外，男性比女性更有可能自我报告患有高血压。因此，该地区扩张的主要原因之一是高血压盛行率的上升。

去肾神经设备市场-竞争格局：

不同产业参与者之间的激烈竞争是全球去肾神经设备市场竞争环境的决定性特征。大型产业参与者正积极采取多种策略来扩大其全球影响力，包括Medtronic PLC、ReCor Medical Inc.（大冢控股有限公司）、St. Jude Medical Inc.（雅培实验室）、Symple Surgical Inc.、 Ablative Solutions Inc.、Covidien PLC、Mercator MedSystems Inc. 等。此外，许多医疗设备製造商、研究机构和医疗保健提供者正在参与市场，努力为去肾神经设备提供新技术和治疗策略。透过伙伴关係、协作以及研发计划，这些参与者致力于推动该领域的发展。此外，产品创新是去肾神经装置市场越来越受欢迎的一大趋势。去肾神经装置市场上的大公司正致力于创造尖端产品，以提高其地位并获得竞争优势。例如，美国医疗器材製造商 ReCor Medical Inc. 于 2021 年 10 月推出了 Paradise 超音波肾去神经系统，用于治疗高血压。该技术使用非聚焦超音波，以侵入性较小的方式治​​疗通往肾臟的过度活跃的神经。与假手术相比，天堂系统已被证明可以成功降低血压。

近期发展

2024 年 6 月：总部位于韩国首尔的医疗器材公司 DeepQure Inc. 表示，其已批准 FDA 的实验器材豁免，目前正在开始 HyperQure 去肾神经 (RDN) 系统的早期可行性研究 (EFS) 。为了治疗顽固性高血压，RDN 使用血管外腹腔镜工具 HyperQure。

2024年4月：根据Recor Medical, Inc.及其母公司大冢医疗器材有限公司发布的声明，FDA已批准Paradise超音波肾臟去神经系统。的Al Qassimi 医院引进中东市场。 Paradise 系统透过使用尖端超音波技术来瞄准和中断过度活跃的肾臟神经元，提供了一种革命性的治疗难治性高血压的方法。

2023年11月：美国医疗设备企业Recor Medical推出Paradise超音波肾臟去神经疗法。利用超音波技术对肾动脉周围的交感神经进行去神经支配，这是美国第一个获得 FDA 批准的肾去神经疗法。这可以减少可能导致高血压的过度活动。作为高血压治疗领域急需的突破，Paradise 系统在临床测试中显示血压显着下降。

目录

第 1 章：去肾神经设备市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 去肾神经设备市场片段（按技术）
    • 肾臟去神经设备市场片段（按产品）
    • 最终用户的肾臟去神经设备市场片段
    • 去肾神经设备市场片段（按国家/地区）
    • 按地区分類的去肾神经设备市场片段
  • 竞争洞察

第 3 章：去肾神经设备主要市场趋势

  • 去肾神经设备市场驱动因素
    • 市场驱动因素的影响分析
  • 去肾神经设备市场限制
    • 市场限制影响分析
  • 去肾神经装置的市场机会
  • 去肾神经设备市场未来趋势

第 4 章：去肾神经装置产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：去肾神经设备市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：去肾臟神经设备市场格局

  • 2024 年去肾神经设备市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：去肾神经设备市场 - 按技术

  • 概述
    • 按技术分類的细分市场份额分析
    • 射频消融术
    • 近距离放射治疗
    • 基于超音波能量的 RDN
    • 化学消融
    • 其他的

第 8 章：去肾神经设备市场 - 按产品

  • 概述
    • 按产品分類的细分市场占有率分析
    • 单电极
    • 多电极
    • 非冲洗导管
    • 冲洗导管
    • 其他的

第 9 章：肾去神经设备市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊所
    • 心血管研究中心
    • 其他的

第 10 章：去肾神经设备市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美去肾神经设备主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按产品）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲去肾神经设备主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模与预测（按产品）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区去肾臟神经设备主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按技术）
    • 亚太地区市场规模与预测（按产品）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 韩国
    • 日本
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲去肾神经设备主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按技术）
    • 拉丁美洲市场规模与预测（按产品）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲去肾臟神经设备主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 去肾神经设备产业

  • 竞争仪表板
  • 公司简介
    • Medtronic PLC
    • ReCor Medical Inc. (Otsuka Holdings Co. Ltd)
    • St. Jude Medical Inc. (Abbott Laboratories)
    • Symple Surgical Inc.
    • Ablative Solutions Inc.
    • Covidien PLC
    • Mercator MedSystems Inc.
    • Terumo Corporation
    • Kona Medical Inc.
    • Vessix Vascular Inc. (Boston Scientific Corporation)
    • Renal Dynamics Limited
    • DeepQure
    • Johnson & Johnson Private Limited
    • Miracor Medical SA
    • SoniVie (CardioSonic, Inc.)
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4515

REPORT HIGHLIGHT

Renal Denervation Devices Market size was valued at US$ 251.09 Million in 2024, expanding at a CAGR of 40.98% from 2025 to 2032.

A minimally invasive technique called renal denervation attempts to reduce the sympathetic nervous system's activity in the kidneys. A catheter is inserted via the arteries and into the renal arteries, which provide blood to the kidneys. The gadget then sends electricity to the vessel wall's nerves to interfere with the signals that can lead to hypertension. There are several ways to provide the energy, including radiofrequency ablation, ultrasound, and, more recently, chemical injections directly or novel techniques based on percutaneous delivery systems. The growing prevalence of hypertension is one of several factors driving the market's expansion. Furthermore, during the projected period, the renal denervation devices market is anticipated to rise as a result of the growing acceptance of innovative goods. For instance, the medical device business Kalos Medical was awarded Won4.67m (about $3.5m) to develop further their renal denervation medical device for the treatment of hypertension. Technological advancements in renal denervation (RDN) products, the growing elderly population, the short-term and permanent effects of renal denervation procedures, and the rising incidence of uncontrolled and treatment-resistant or drug-resistant hypertension (trHTN) are additional factors propelling the renal denervation devices market growth.

Renal Denervation Devices Market- Market Dynamics

Rising Prevalence of Hypertension

The market for renal denervation devices is anticipated to develop in the future due to the rising prevalence of hypertension. When the force of blood flowing through the blood arteries is continuously too high, it is referred to as hypertension or high blood pressure. For patients with resistant hypertension, renal denervation-a catheter-based procedure-has become a viable treatment option. A minimally invasive, experimental treatment for hypertension that has not improved with medicines is renal denervation. For instance, in January 2023, the Mississippi State Department of Health, a Mississippi state health department situated in the United States, reported that approximately 1 million adult Mississippians (43.9%) had high blood pressure in 2021. The prevalence of hypertension was 36.3% greater in MS in 2021 than in the US (MS: 43.9%, US: 32.2%). Thus, the market for renal denervation devices will expand as a result of the rising incidence of hypertension.

Renal Denervation Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 40.98% over the forecast period (2025-2032)

Based on technology segmentation, radio frequency ablation was predicted to show maximum market share in the year 2024

Based on end-user segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Renal Denervation Devices Market- Segmentation Analysis:

The Global Renal Denervation Devices Market is segmented on the basis of Technology, Product, End-user, and Region.

On the basis of technology, the market is segregated into Radio Frequency Ablation, Brachytherapy, Ultrasound Energy-based RDN, Chemical Ablation, and Others. In 2024, the market was dominated by the radio frequency ablation category because of its established market presence and the large number of successful surgeries carried out using this technology. This technique, which has been widely used since its inception, uses radiofrequency energy to break up hyperactive renal nerves. For instance, Kauvery Hospital in India introduced a novel renal denervation treatment based on radiofrequency for persistent hypertension in May 2024. The Indian government-approved technique demonstrated promising outcomes in lowering nerve activity and treating severe, drug-resistant hypertension, highlighting the technology's market leadership.

Based on end-user, the market is divided into Hospitals, Clinics, Cardiovascular research centre, and Others. In 2024, the hospitals category held a dominant market share because of their sophisticated infrastructure, highly skilled personnel, and resources for intricate processes. Due to well-established reimbursement structures and supportive healthcare policies that make it easier for patients to receive state-of-the-art therapies, these facilities are very successful at handling cases of resistant hypertension. Hospitals are essential for clinical trials that assess the safety and effectiveness of novel renal denervation therapies, in addition to their core duties. The field is advanced by this research, which also aids in the early integration of novel tools and methods into standard medical practice. These institutes enhance treatment regimens for hypertension patients by actively engaging in trials and helping to develop evidence-based procedures.

Renal Denervation Devices Market- Geographical Insights

In 2024, North America led the renal denervation devices industry, mostly due to significant technological advancements and a high amount of FDA approval requests. In 2023, the FDA authorized the "Symplicity Spyral System and Ultrasound-based Paradise Device" as one of two renal denervation devices in the US. Furthermore, the region's dominance is attributed to a number of factors, including an ageing population, changing lifestyles, and the high prevalence of hypertension. The market's growth is also primarily driven by increasing R&D efforts to produce efficient devices. The rise in local new launches is another aspect propelling the renal denervation devices market's growth.

The market for renal denervation devices is anticipated to develop significantly in Europe due to factors like the procedure's long-lasting effects, rising rates of hypertension, and increased technological advancements. For instance, according to data from the Office of Health Improvement and Disparities, 8,457,600 people in England had hypertension in 2021. Furthermore, 73.6% of respondents to a survey done in Italy in 2021 said they were aware of their blood pressure, 42.3% said they had been diagnosed with hypertension, and 41.4% said they were taking antihypertensive drugs. Additionally, men were more likely than women to self-report having hypertension. Consequently, one of the main causes of the region's expansion is the rising prevalence of hypertension.

Renal Denervation Devices Market- Competitive Landscape:

The fierce rivalry between different industry participants is a defining feature of the competitive environment of the worldwide renal denervation devices market. Large industry participants are aggressively pursuing a number of tactics to bolster their worldwide footprint, including Medtronic PLC, ReCor Medical Inc. (Otsuka Holdings Co. Ltd), St. Jude Medical Inc. (Abbott Laboratories), Symple Surgical Inc., Ablative Solutions Inc., Covidien PLC, Mercator MedSystems Inc., and others. Furthermore, numerous medical device makers, research institutes, and healthcare providers are participating in the market in an effort to provide novel technologies and treatment strategies for renal denervation devices. Through partnerships, collaborations, and research and development initiatives, these players are committed to furthering the area. Additionally, product innovation is a major trend that is becoming more and more popular in the market for renal denervation devices. Large firms in the market for renal denervation devices are concentrating on creating cutting-edge goods to improve their standing and obtain a competitive edge. For instance, ReCor Medical Inc., a US-based manufacturer of medical devices, introduced the Paradise Ultrasound Renal Denervation System in October 2021 to treat hypertension. Using non-focused ultrasound, this technique treats hyperactive nerves that go to the kidney in a less invasive manner. When compared to a sham operation, the Paradise System has been demonstrated to lower blood pressure successfully.

Recent Development

June 2024: DeepQure Inc., a medical device business based in Seoul, South Korea, stated that it has approved an experimental device exemption from the FDA and is now beginning an early feasibility study (EFS) for the HyperQure renal denervation (RDN) system. For the treatment of resistant hypertension, RDN uses the extravascular laparoscopic tool HyperQure.

April 2024: The FDA has approved the paradise ultrasound renal denervation system, according to a statement released by Recor Medical, Inc. and its parent firm, Otsuka Medical Devices Co., Ltd. This cutting-edge technology, which is currently on the market, was recently introduced to the Middle Eastern market at Al Qassimi Hospital in Sharjah, United Arab Emirates. The Paradise system offers a revolutionary approach to treating resistant hypertension by using cutting-edge ultrasound technology to target and interrupt hyperactive renal neurons.

November 2023: The US-based medical equipment business Recor Medical introduced Paradise Ultrasound Renal Denervation Therapy. The sympathetic nerves around the renal arteries are denervated utilizing ultrasound technology, which is the first FDA-approved renal denervation therapy in the US. This reduces the overactivity that can cause hypertension. As a much-needed breakthrough in the management of hypertension, the Paradise System has demonstrated notable drops in blood pressure in clinical testing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RENAL DENERVATION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic PLC
  • ReCor Medical Inc. (Otsuka Holdings Co. Ltd)
  • St. Jude Medical Inc. (Abbott Laboratories)
  • Symple Surgical Inc.
  • Ablative Solutions Inc.
  • Covidien PLC
  • Mercator MedSystems Inc.
  • Terumo Corporation
  • Kona Medical Inc.
  • Vessix Vascular Inc. (Boston Scientific Corporation)
  • Renal Dynamics Limited
  • DeepQure
  • Johnson & Johnson Private Limited
  • Miracor Medical SA
  • SoniVie (CardioSonic, Inc.)
  • Others

GLOBAL RENAL DENERVATION DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Radio Frequency Ablation
  • Brachytherapy
  • Ultrasound Energy-based RDN
  • Chemical Ablation
  • Others

GLOBAL RENAL DENERVATION DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Single electrode
  • Multi Electrode
  • Non irrigated catheter
  • Irrigated Catheter
  • Others

GLOBAL RENAL DENERVATION DEVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Cardiovascular research centre
  • Others

GLOBAL RENAL DENERVATION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Renal Denervation Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Renal Denervation Devices Market Snippet by Technology
    • 2.1.2. Renal Denervation Devices Market Snippet by Product
    • 2.1.3. Renal Denervation Devices Market Snippet by End-user
    • 2.1.4. Renal Denervation Devices Market Snippet by Country
    • 2.1.5. Renal Denervation Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Renal Denervation Devices Key Market Trends

  • 3.1. Renal Denervation Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Renal Denervation Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Renal Denervation Devices Market Opportunities
  • 3.4. Renal Denervation Devices Market Future Trends

4. Renal Denervation Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Renal Denervation Devices Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Renal Denervation Devices Market Landscape

  • 6.1. Renal Denervation Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Renal Denervation Devices Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Radio Frequency Ablation
    • 7.1.3. Brachytherapy
    • 7.1.4. Ultrasound Energy-based RDN
    • 7.1.5. Chemical Ablation
    • 7.1.6. Others

8. Renal Denervation Devices Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 8.1.2. Single electrode
    • 8.1.3. Multi Electrode
    • 8.1.4. Non irrigated catheter
    • 8.1.5. Irrigated Catheter
    • 8.1.6. Others

9. Renal Denervation Devices Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Cardiovascular research centre
    • 9.1.5. Others

10. Renal Denervation Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Renal Denervation Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Renal Denervation Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Renal Denervation Devices Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Renal Denervation Devices Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Renal Denervation Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Renal Denervation Devices Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Medtronic PLC
    • 11.2.2. ReCor Medical Inc. (Otsuka Holdings Co. Ltd)
    • 11.2.3. St. Jude Medical Inc. (Abbott Laboratories)
    • 11.2.4. Symple Surgical Inc.
    • 11.2.5. Ablative Solutions Inc.
    • 11.2.6. Covidien PLC
    • 11.2.7. Mercator MedSystems Inc.
    • 11.2.8. Terumo Corporation
    • 11.2.9. Kona Medical Inc.
    • 11.2.10. Vessix Vascular Inc. (Boston Scientific Corporation)
    • 11.2.11. Renal Dynamics Limited
    • 11.2.12. DeepQure
    • 11.2.13. Johnson & Johnson Private Limited
    • 11.2.14. Miracor Medical SA
    • 11.2.15. SoniVie (CardioSonic, Inc.)
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us